key: cord-0959090-yq9wegaz authors: Ting, Frederic Ivan; Sacdalan, Danielle Benedict; Cortez, Jana Laine; Pacana, Ma. Alfina Diana; Jimeno, Cecilia title: COVID-19 in Cancer Patients Can Be Challenging to Screen in a Resource Limited Setting date: 2020-09-29 journal: Cancer Treat Res Commun DOI: 10.1016/j.ctarc.2020.100214 sha: ceb20223f7140f732af3db40c8b63c279f665dfc doc_id: 959090 cord_uid: yq9wegaz During this COVID-19 pandemic, patients with symptoms such as fever, cough, sore throat, coryza were advised to have RT-PCR testing for SARS-COV2 infection. We described here an elderly patient with chronic lymphocytic leukemia, who presented with atypical symptoms that were not directly attributable to COVID-19. This patient was admitted to the non-COVID-19 ward for supportive care. Later, her chest x-ray revealed pneumonia that was confirmed to be COVID-19 by RT-PCR testing several days later. In resource-poor settings where molecular testing results suffered from delays or were altogether unavailable, the use of diagnostic imaging such as a chest x-ray could serve as a quick guide in the assessment and management of these patients especially if the imaging results suggest COVID-19 infection. One of the recommendations by the World Health Organization in the screening and triage of patients for potential SARS-CoV-2 infection is the interrogation for associated symptoms such as fever, cough, sore throat, anosmia, and coryza. (1, 2) However, symptoms and clinical presentation may vary among patients and other objective parameters may assist in effectively screening patients for potential COVID-19 infection. A 63-year-old female with Chronic Lymphocytic Leukemia (CLL) presented at our hospital for blood transfusion. At the time of her admission at the medicine ward, she had minimal non-productive cough which the patient claimed had been present for several months already. Other respiratory symptoms, fever, and diarrhea were all absent. This patient had no history of recent international travel, contact with someone coming from overseas, nor with a known case of COVID-19. Physical examination revealed tachycardia and fine bi-basal rales. Complete blood count on admission showed hypochromic anemia with anisocytosis, thrombocytopenia, and leukocytosis with lymphocytic predominance (Table 1 .). A chest radiograph was done for further evaluation. The chest radiograph (Figure 1 ), showed interval development of patchy inhomogeneous opacities in both lungs with confluence in the mid to lower lung zones suggestive of pneumonia. This change was noted in comparison to a radiograph taken during a prior admission four weeks earlier during which time her CLL was diagnosed. A decision was made to treat her pneumonia with antibiotics. As the COVID-19 pandemic had just been declared, testing for SARS-CoV-2 infection was likewise done. Due to concerns that the patient could have COVID-19 she was promptly transferred to a separate unit for isolation. All exposed staff were immediately advised to self-quarantine. Other patients in proximity to the case were monitored closely for signs and symptoms of COVID-19. Five days later, her reverse transcription -polymerase chain reaction (RT-PCR) results came out positive for COVID-19 and the patient was immediately transferred to the COVID-19 dedicated unit. Fortunately, at the end of the prescribed quarantine period no personnel nor additional patients developed COVID-19 infection due to this exposure. The patient recovered from COVID-19 after an eight-week admission. Patients with hematologic malignancies are at an increased risk for infection arising from their malignancy and from the interventions being given for their treatment. CLL is a profoundly immunosuppressed state. The clinical course of the infection for immunosuppressed patients may also vary from mild to critical disease. (6) : 56-80) . A criticism of x-rays was its lack of sensitivity needed to detect ground-glass opacities (GGOs) that were early manifestations of COVID-19 on imaging.(9) In addition, imaging results also needed to be correlated with clinical findings as the absence of typical findings on chest x-ray would not preclude the diagnosis of COVID-19. The meta-analysis had significant heterogeneity and sensitivity was highest for the three studies that were conducted in Wuhan, China (97, 96 and 99%,respectively) . For the studies done outside Wuhan, sensitivity ranged from 62-98%. Specificity was reported by only two studies at 25% (95% CI: 22-30) and 33% (95% CI: 23-44) , respectively. GGOs and consolidative opacities are among the most common CT findings associated with COVID-19.(10) Concerns with the use of chest CT for the screening of potential COVID-19 cases is that this procedure can be logistically difficult and more expensive than a chest x-ray. Moreover, dedicated machines for screening potential COVID-19 patients are not always available especially in resource-constrained settings. Lastly, the CT scanners and the staff manning these can become vectors of infection particularly to vulnerable patients. (11, 12) Lung ultrasound is emerging as a promising point-of-care tool to diagnose COVID-19 and efforts to standardize the use of this modality have come forth. (13) Although it has several advantages compared to CT scans including the absence of radiation, lower cost, portability, and lower contamination risk, perhaps the most significant challenge with the use of lung ultrasound remains to be its potential for subjectivity and its reliance on the experience and expertise of the sonographer. (14, 15) In resourceconstrained settings where trained personnel are not readily available, treatment decision-making and resource allocation may need to rely on more objective bases for the diagnosis of COVID-19. Considering the strengths of each modality and the availability of resources to us, the Department of Medicine at our Center included chest radiography as part of the initial diagnostics for patients scheduled for admission to its non-COVID-19 wards. As quarantine measures are eased the challenge of resuming patient services is one that requires much thought. Point of care (POC) antibody tests may have value in identifying patients with cancer who have recovered from COVID-19. Unfortunately, data shows that individuals with cancer exhibit lower rates of seroconversion compared to those without malignancy. Moreover, it appears that prior cytotoxic or surgical therapy within four weeks of SARS-CoV-2 infection may affect seroconversion in patients with cancer. (17, 18) More studies are needed to elucidate the effect of cancer and its treatment on the immune response to COVID-19; and as a corollary, how serologic testing can guide screening and treatment decision-making at the clinic. It remains unlikely from available data that these POC tests will supplant RT-PCR in the diagnosis of COVID-19. The goal is to ensure that patients are given appropriate care while mitigating the risk of acquiring COVID-19. In a resource-poor setting where results for COVID-19 RT-PCR tests are delayed or where it is unavailable, the use of diagnostic imaging such as a chest x-ray may be a quick guide in the assessment and management of these patients especially if the imaging results are suggestive of COVID-19 infection. Further study into the value of diagnostic imaging and serologic testing are needed for high-risk patients with cancer since symptomatic triaging for COVID-19 may be too challenging. The authors have obtained informed consent from the patient in this report. All identifying information have been anonymized. World Health Organization. Maintaining essential health services: operational guidance for the COVID-19 context Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. ESMO Open Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? Progress and prospect on imaging diagnosis of COVID-19 Diagnostic impact of bedside chest X-ray features of 2019 novel coronavirus in the routine admission at the emergency department: case series from Lombardy region Progress and prospect on imaging diagnosis of COVID-19 Chest CT for Detecting COVID-19: A Systematic Review and Meta-Analysis of Diagnostic Accuracy A role for CT in COVID-19? What data really tell us so far The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review COVID-19 outbreak: less stethoscope, more ultrasound Lung ultrasound in the diagnosis of COVID-19 infection -A case series and review of the literature Why, when, and how to use lung ultrasound during the COVID-19 pandemic: enthusiasm and caution Journal -2010 -New engla nd journal Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19 Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19